These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Behavioral effects of alprazolam in humans. Kelly TH; Foltin RW; Serpick E; Fischman MW Behav Pharmacol; 1997 Feb; 8(1):47-57. PubMed ID: 9833000 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. II. Triazolam. Gupta SK; Ellinwood EH; Nikaido AM; Heatherly DG Pharm Res; 1990 Jun; 7(6):570-6. PubMed ID: 2367325 [TBL] [Abstract][Full Text] [Related]
10. Kinetics and dynamics of intravenous adinazolam, N-desmethyl adinazolam, and alprazolam in healthy volunteers. Venkatakrishnan K; Culm KE; Ehrenberg BL; Harmatz JS; Corbett KE; Fleishaker JC; Greenblatt DJ J Clin Pharmacol; 2005 May; 45(5):529-37. PubMed ID: 15831776 [TBL] [Abstract][Full Text] [Related]
11. The effects of alprazolam and buspirone in light and moderate female social drinkers. Evans SM; Levin FR Behav Pharmacol; 2002 Sep; 13(5-6):427-39. PubMed ID: 12394419 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study. Riba J; Rodríguez-Fornells A; Urbano G; Morte A; Antonijoan R; Barbanoj MJ Psychopharmacology (Berl); 2001 Oct; 157(4):358-67. PubMed ID: 11605094 [TBL] [Abstract][Full Text] [Related]
13. Respiratory and sedative effects of triazolam in volunteers. Longbottom RT; Pleuvry BJ Br J Anaesth; 1984 Feb; 56(2):179-85. PubMed ID: 6140935 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration. Smith RB; Kroboth PD; Vanderlugt JT; Phillips JP; Juhl RP Psychopharmacology (Berl); 1984; 84(4):452-6. PubMed ID: 6152055 [TBL] [Abstract][Full Text] [Related]
15. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers. Hallam KT; Olver JS; McGrath C; Norman TR Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of adinazolam and N-desmethyladinazolam after oral and intravenous dosing in healthy young and elderly volunteers. Fleishaker JC; Hulst LK; Ekernäs SA; Grahnén A J Clin Psychopharmacol; 1992 Dec; 12(6):403-14. PubMed ID: 1474178 [TBL] [Abstract][Full Text] [Related]
17. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans. Evans SM; Troisi JR; Griffiths RR J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783 [TBL] [Abstract][Full Text] [Related]
18. Assessment of the anxiolytic and amnesic effects of three benzodiazepines, diazepam, alprazolam and triazolam, by conflict and non-matching to sample tests in mice. Kuribara H; Asahi T Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Feb; 17(1):1-6. PubMed ID: 9134532 [TBL] [Abstract][Full Text] [Related]
19. A neurophysiological study of the detrimental effects of alprazolam on human action monitoring. Riba J; Rodríguez-Fornells A; Münte TF; Barbanoj MJ Brain Res Cogn Brain Res; 2005 Oct; 25(2):554-65. PubMed ID: 16168630 [TBL] [Abstract][Full Text] [Related]
20. Orally delivered alprazolam, diazepam, and triazolam as reinforcers in rhesus monkeys. Gomez TH; Roache JD; Meisch RA Psychopharmacology (Berl); 2002 Apr; 161(1):86-94. PubMed ID: 11967635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]